Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show

Tafenoquine, a prodrug that could fulfill the criteria for a mass eradication campaign.

Measuring blood plasma viscosity in COVID-19 using Brillouin light scattering spectroscopy

A research team led by MedUni Vienna has shown in a study that purely optical measurements of the viscosity of blood plasma may provide information

August 6, 2024

Indivior axes schizophrenia drug and shrinks revenue guidance

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 13, 2024

Cytokinetics looks to take on BMS’ Camzyos in hypertrophic cardiomyopathy

Cytokinetics’s aficamten is a myosin inhibitor that reduces the interaction between actin and myosin to prevent muscle hypercontractility. Image Credit: Michael Vi / Shutterstock. Cytokinetics

May 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.